Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Evidence Ledger: What the Research Actually Shows Plain statement: No phase II or III human RCT for BPC-157 in any indication has been published as of May 2026
Storage Instructions Store at -20C for long-term stability Avoid repeated freezethaw cycles Keep vial sealed and dry Protect from light and moisture Safety, Risks & Scientific Limitations Although widely discussed in research communities, it is critical to understand: No FDA or TGA approval exists No large-scale human clinical trials Long-term safety remains unknown Effects on human biology are not confirmed Additionally, theoretical concerns include: Angiogenesis-related growth pathway risks Unknown endocrine interactions Immune modulation uncertainty Lack of pharmacokinetic data Potential Research Applications (Not Human Use) It is important to emphasize that all applications are strictly theoretical and laboratory-based : Musculoskeletal tissue research Cellular regeneration models Inflammatory pathway studies Angiogenesis and vascular research Connective tissue response analysis Why Choose Buy Australia Peptides
[18] Lactation studies demonstrate that maternal injections modestly elevate breast-milk B12 concentrations without adverse infant outcomes, supporting compatibility with breastfeeding while underscoring the need for maternal repletion to prevent neonatal deficiency
Frontier Peptide Labs 5-Amino-1MQ Capsules are intended exclusively for laboratory research and development purposes
Hormone disruption: It doesn't affect testosterone, estrogen, thyroid, or other hormones
US$ 23.83
US$ 23.43
US$ 29.70
US$ 23.90
US$ 23.95
US$ 27.88
US$ 28.63
US$ 24.29
US$ 24.53
